A Biotech Founder Makes the Moral Case for Gene-Editing Human Embryos
Any changes made could be passed on to future generations. That could mean, for example, correcting a devastating genetic mutation for good. But accidental DNA edits elsewhere, known as “off-target effects,” could introduce new health risks that could also be passed down.
- ▪Any changes made could be passed on to future generations.
- ▪That could mean, for example, correcting a devastating genetic mutation for good.
- ▪But accidental DNA edits elsewhere, known as “off-target effects,” could introduce new health risks that could also be passed down.
WIRED files mainly under tech. We currently carry 983 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | WIRED |
| Canonical URL | https://www.wired.com/story/biotech-founder-cathy-tie-moral-case-gene-editing-human-embryos/ |
| Publication time | Wed, 30 Sep 2026 14:30:00 +0000 |
| Retrieval time | 2026-09-30T14:37:01.543Z |
| Last seen | 2026-09-30T14:37:01.543Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | VzfnQK7RYGTX · 1 stories |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
Kristen V. BrownScienceSep 30, 2026 10:30 AMA Biotech Founder Makes the Moral Case for Gene-Editing Human EmbryosThe practice of editing the genes of embryos remains highly controversial and risky, but Origin Genomics founder Cathy Tie argues its a “moral imperative” to address hereditary diseases.Photo-Illustration: Wired Staff; Getty ImagesCommentLoaderSave StorySave this storyCommentLoaderSave StorySave this storyWhen the Chinese scientist He Jiankui announced in 2018 that he had created the first gene-edited babies, the experiment was widely condemned as reckless and premature.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at WIRED.
Discussion
0 commentsMore from WIRED
